SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-13-004986
Filing Date
2013-01-31
Accepted
2013-01-31 12:16:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 RULE 424(B)(5) v333402_424b5.htm 424B5 307980
2 GRAPHIC logo.jpg GRAPHIC 7080
3 GRAPHIC tlogo1.jpg GRAPHIC 32906
  Complete submission text file 0001144204-13-004986.txt   364432
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-173752 | Film No.: 13561578
SIC: 2835 In Vitro & In Vivo Diagnostic Substances